◆ 会议时间：2024年10月23-27日
◆ 会议地点：中国 台湾-台北
◆ 会议简介：
2024年第9届亚洲-大洋洲免疫学会联合会(FIMSA)大会将于2024年10月23-27日在中国台湾台北举行。
亚洲-大洋洲免疫学会联合会(FIMSA)是于1992年成立的非营利性组织，其宗旨是促进亚太地区的免疫学科学的发展。所有亚太地区的免疫学学会和协会，只要是国际免疫学学会联合会(IUIS)的成员，都有资格成为FIMSA的成员。目前成员包括澳大利亚和新西兰、中国大陆、台湾、香港、印度、伊朗、日本、韩国、巴布亚新几内亚、新加坡、泰国和斯里兰卡。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）
The 9th Federation of Immiological Societies of Asia-Ocenia Congress (FIMSA 2024)
Date: October 23-27， 2024
Venue: Taipei International Conference Center (TICC), Taipei, Taiwan, China
Hosting Societies
台湾免疫学会/The Chinese Society of Immunology (CSI)
Co-Hosting
The Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI)
摘要征文投稿：
Abstract Submission System Open: 00:00, 01 October 2023 (GMT+8)
Deadline for Abstract Submission: 23:59, 15 March 2024 (GMT+8)
Notification of Acceptance: 09:00-17:00, 15 May 2024 (GMT+8)
点此提交摘要>>>Submit Abstract>>>
General Policy
- All abstracts must be submitted and be received on or before March 15, 2024 through On-line Abstract Submission System.
- Abstracts must be original and have not been published or presented at any congress prior to the FIMSA 2024. The accepted abstracts will be published in the Abstract Book.
- All abstracts will be reviewed by the Scientific Program Committee of the FIMSA 2024 and reviewing results will be announced by emailing a notice of acceptance / rejection to presenting authors only by May 15, 2024. Instruction for oral / poster presentation will be sent to presenting authors of the accepted abstracts. Thus, authors must register and pay the registration fees before Deadline for Early Bird Registration to ensure the rights for the presentation.
- The Scientific Program Committee of FIMSA 2024 reserves the right to accept or refuse an abstract, to designate abstracts either oral or poster presentation and to choose a suitable session for the abstract. The authors’ preference of the type of the presentation and theme will be taken into account.
- The number of abstracts for each account is limited to TWO.
- Accepted abstracts will be presented in either thematic Poster Sessions or Oral Sessions presented between 23-27 October 2024.
- Authors of abstracts accepted for presentation MUST be registered delegates and be responsible for all expenses incurred in the production of their presentations, travel and accommodation during the Congress.
- It is the author’s responsibility to submit a correctly edited and accurate abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author. Abstracts will be rejected if they contain no data or if the English is unacceptable. All Presenting Authors will receive, closer to the Congress, detailed presentation guidelines when their abstract/s has/have been accepted.
- Acknowledgement of the receipt of abstract submission will be sent to the Presenting Author’s email address immediately upon submission. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email that is provided in the abstract submission.
- All presentations must be in English.
Abstract Categories
- Mucosa Immunity
- Cancer Immunity
- Autoimmunity
- Immune Regulation and Inflammation
- Host-Pathogen Interaction
- Allergic Reaction
- Others
Submission Preparation Guideline
- The abstract must be written and presented in English.
- All the works intended to present at the congress should be submitted as abstracts.
- Before submitting, please prepare your submission strictly according to the guideline. As the contents, format and layout of submitted abstracts would NOT be revised nor modified by the FIMSA 2024 congress secretariat, should the submissions received do not meet the specification, FIMSA 2024 Scientific Program Committee reserves the right to reject the submission outright.
- The User of this Account would be recognizing as the Presenting Author of each submitted papers.
- The number of co-authors of each abstract is limited to 10, however, should the co-authors are not filling in the submission system, the co-authors will not be shown on the abstract book. Thus, please make sure the co-author(s) fill in the submission system is consistent with the co-author(s) shown on the submitted abstract.
- Preference for presentation type should be indicated in your submission. However, the final presentation made for each paper will be decided by the Scientific Program Committee's evaluation and will be advised to the author within the acceptance notice.
- No encore abstracts are accepted.
- Abstracts must contain original data and meet international ethical standards.
- The abstract title and the author(s) or names of institutions are not to be included in the abstract text.
- Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time the full wording appears in the body of the text.
- Trade names are not allowed.
- The Author agrees to and does hereby assign all rights, title and interest, including copyrights, in and to the abstract to the Publisher. When the abstract is ready for publication, it will be published at the Publisher's own expense, under the Publisher's name in a congress abstract.
- This abstract conforms to all of the 9th Federation of Immiological Societies of Asia-Ocenia Congress (FIMSA 2024) Abstract Rules and Procedures.
Instructions for Preparing Abstracts
Please read the following instructions carefully before preparing your abstract.
To ensure that the Abstract Submission System will work properly, the pop-up blocker of your internet browser needs to be turned off and cookies should be enabled. Abstract authors should not split data to create several abstracts from one data set. If splitting is deemed to have occurred, scores of related abstracts may be reduced or abstracts simply rejected.
*Before Submitting, please prepare your abstract strictly according to the Abstract Guideline. If abstracts received do not meet the specification, Scientific Program Committee reserves the right to reject the submission.On-line Abstract Submission
- Complete the abstract submission form at On-line Abstract Submission System.
You will be given detailed instructions on how to proceed.
- Each abstract can only be submitted once. The same abstract cannot be submitted for consideration in different paper categories.
- The indication of the preferable presentation type (Oral Presentation / Poster Presentation) is required.
- An acknowledgement of the receipt of the abstract will be sent automatically to the presenting author by e-mail upon the online submission.
- For those who has difficulty in accessing the on-line abstract submission system, please contact the FIMSA 2024 Abstract & Registration Office at fimsa2024reg@elitepco.com.tw.
Applicants of the Best Paper and/or Best Poster Award must meet the followings:
- Submit a paper and be the presenting author of the presentation.
- Complete the online registration and pay the registration fee no later than 15 June, 2024.
- Each winner is entitled to free registration and a US$300 monetary award.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
